The Journal of international medical research
The most recent articles from:
J. Int. Med. Res.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron.
Control of nausea and vomiting is very important in determining patient compliance with cisplatin chemotherapy. A multicentre, randomized, single-blind study was conducted to compare the tolerability and efficacy of ramosetron with those of granisetron over 24 h following cisplatin administration to cancer patients. ⋯ In the tolerability evaluation, there were no statistically significant differences between the two groups, except for a higher incidence of dull headache in the granisetron group. Ramosetron and granisetron appear to have equivalent efficacy and tolerability profiles, but the effects of ramosetron on the prevention of acute vomiting in patients undergoing cisplatin chemotherapy were longer lasting.